Skip to main content

Generate Biomedicines, Inc.

GENB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002100782

In the last 90 days, Generate Biomedicines, Inc. insiders filed 0 open-market purchases and 2 sales; 108 institutions reported holding it in 13F filings for Q3 2026, worth $1.60B in total; ARK Invest is the only superinvestor holding it.

Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Nov 13, 2026, 1:25 AM ET

No financial statements

Generate Biomedicines, Inc. has no annual statements on file yet. See the quarterly statements.